Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Novartis Ag (NVSEF) Leases (2019 - 2025)

Historic Leases for Novartis Ag (NVSEF) over the last 9 years, with Q4 2025 value amounting to $1.6 billion.

  • Novartis Ag's Leases rose 1095.41% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year increase of 1095.41%. This contributed to the annual value of $1.6 billion for FY2025, which is 1095.41% up from last year.
  • Per Novartis Ag's latest filing, its Leases stood at $1.6 billion for Q4 2025, which was up 1095.41% from $1.5 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Leases high stood at $1.6 billion for Q2 2021, and its period low was $12.0 million during Q1 2022.
  • For the 5-year period, Novartis Ag's Leases averaged around $1.3 billion, with its median value being $1.4 billion (2022).
  • Per our database at Business Quant, Novartis Ag's Leases surged by 490312.5% in 2021 and then crashed by 9925.05% in 2022.
  • Novartis Ag's Leases (Quarter) stood at $1.6 billion in 2021, then fell by 8.33% to $1.4 billion in 2022, then dropped by 1.47% to $1.4 billion in 2023, then grew by 0.35% to $1.4 billion in 2024, then grew by 10.95% to $1.6 billion in 2025.
  • Its Leases was $1.6 billion in Q4 2025, compared to $1.5 billion in Q3 2025 and $1.4 billion in Q2 2025.